staurosporine aglycone has been researched along with Leukemia, Myeloid, Acute in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rao, R | 1 |
Nalluri, S | 1 |
Fiskus, W | 1 |
Balusu, R | 1 |
Joshi, A | 1 |
Mudunuru, U | 1 |
Buckley, KM | 1 |
Robbins, K | 1 |
Ustun, C | 1 |
Reuther, GW | 1 |
Bhalla, KN | 1 |
1 other study available for staurosporine aglycone and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Heat shock protein 90 inhibition depletes TrkA levels and signaling in human acute leukemia cells.
Topics: Animals; Benzoquinones; Bone Marrow Cells; Carbazoles; Cell Differentiation; Cell Line, Tumor; Cocul | 2010 |